Literature DB >> 28639238

Multiple Sclerosis in Latin Americans: Genetic Aspects.

Victor M Rivera1.   

Abstract

Latin Americans (LA) are a heterogeneous, multiethnic group of individuals who inhabit the continental countries in Latin America (LATAM), Caribbean islands and constitute the largest ethnic minority in the USA. Commonly used terminology and ethno racial classifications to define these groups may not be accurate. Risk for multiple sclerosis (MS) among LA is generally low to medium but frequencies are increasing in the American hemisphere. Genome-Wide Association Studies (GWAS) in LA show diverse variants and genetic proportions among Mestizos, the most representative ethnic population, who themselves are the product of centuries of interracial mixing between Native Americans (or Amerindians), White Caucasian Europeans, and Black Africans. Genetic distribution diversity appears to be related to migratory and historical and socio-political factors in LATAM. Epidemiologic studies show an extremely low prevalence of MS among non-mixed Amerindians; this has been attributed to protective ancestral Asian genetics and possibly, environmental factors. Mestizos and biracial LA of African ancestry have more susceptibility to MS apparently due to the historical introduction of the European HLA-DRB1*1501 gene. Contribution from HLA typing, GWAS, and ancestry informative markers (AIMs) has been determinant in the current LA genetic understanding but more regional studies are needed. The relationship between genetics and disease regional distribution is emphasized.

Entities:  

Keywords:  Amerindians; Genetics; Latin Americans; Mestizo; Multiple sclerosis

Mesh:

Year:  2017        PMID: 28639238     DOI: 10.1007/s11910-017-0768-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  41 in total

1.  HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.

Authors:  C Alvarado-de la Barrera; J Zúñiga-Ramos; J A Ruíz-Morales; B Estañol; J Granados; L Llorente
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  MS and neuromyelitis optica in Martinique (French West Indies).

Authors:  P Cabre; O Heinzlef; H Merle; G G Buisson; O Bera; R Bellance; J C Vernant; D Smadja
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

3.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.

Authors:  Irma Silva-Zolezzi; Alfredo Hidalgo-Miranda; Jesus Estrada-Gil; Juan Carlos Fernandez-Lopez; Laura Uribe-Figueroa; Alejandra Contreras; Eros Balam-Ortiz; Laura del Bosque-Plata; David Velazquez-Fernandez; Cesar Lara; Rodrigo Goya; Enrique Hernandez-Lemus; Carlos Davila; Eduardo Barrientos; Santiago March; Gerardo Jimenez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

4.  [Prevalence of multiple sclerosis in Colombia].

Authors:  J L Sánchez; C Aguirre; O M Arcos-Burgos; I Jiménez; M Jiménez; F León; J Pareja; G Pradilla; B Uribe; C S Uribe; A Villa; M Volcy; L G Palacio
Journal:  Rev Neurol       Date:  2000 Dec 16-31       Impact factor: 0.870

5.  Multiple sclerosis in Mexico: hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City.

Authors:  T Corona; J L Rodrigues; E Otero; L Stopp
Journal:  Neurologia       Date:  1996-05       Impact factor: 3.109

6.  Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients.

Authors:  S V Alves-Leon; R Papais-Alvarenga; M Magalhães; M Alvarenga; L C S Thuler; O Fernández y Fernandez
Journal:  Acta Neurol Scand       Date:  2007-05       Impact factor: 3.209

7.  Prevalence of multiple sclerosis in First Nations people of Alberta.

Authors:  Lawrence W Svenson; Sharon Warren; Kenneth G Warren; Luanne M Metz; Scott B Patten; Donald P Schopflocher
Journal:  Can J Neurol Sci       Date:  2007-05       Impact factor: 2.104

8.  Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.

Authors:  E Quelvennec; O Bera; P Cabre; M Alizadeh; D Smadja; F Jugde; G Edan; G Semana
Journal:  Tissue Antigens       Date:  2003-02

Review 9.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

10.  Geographic patterns of genome admixture in Latin American Mestizos.

Authors:  Sijia Wang; Nicolas Ray; Winston Rojas; Maria V Parra; Gabriel Bedoya; Carla Gallo; Giovanni Poletti; Guido Mazzotti; Kim Hill; Ana M Hurtado; Beatriz Camrena; Humberto Nicolini; William Klitz; Ramiro Barrantes; Julio A Molina; Nelson B Freimer; Maria Cátira Bortolini; Francisco M Salzano; Maria L Petzl-Erler; Luiza T Tsuneto; José E Dipierri; Emma L Alfaro; Graciela Bailliet; Nestor O Bianchi; Elena Llop; Francisco Rothhammer; Laurent Excoffier; Andrés Ruiz-Linares
Journal:  PLoS Genet       Date:  2008-03-21       Impact factor: 5.917

View more
  4 in total

1.  Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

Authors:  Lisa E Creary; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Mult Scler       Date:  2018-04-23       Impact factor: 6.312

Review 2.  Towards a global view of multiple sclerosis genetics.

Authors:  Huw R Morris; Ruth Dobson; Benjamin Meir Jacobs; Michelle Peter; Gavin Giovannoni; Alastair J Noyce
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

3.  Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

Authors:  G V González-Enríquez; B M Torres-Mendoza; J Márquez-Pedroza; M A Macías-Islas; G G Ortiz; J A Cruz-Ramos
Journal:  Immunogenetics       Date:  2018-02-03       Impact factor: 2.846

4.  Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines.

Authors:  Victor M Rivera
Journal:  Biomedicines       Date:  2018-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.